P-Glycoprotein Silencing with siRNA Delivered by Dope-Modified Pei Overcomes Doxorubicin Resistance in Breast Cancer Cells

Abstract

The combination of doxorubicin and P-gp silencing formulations led to a twofold increase of doxorubicin uptake and a significant improvement of the therapeutic effect of doxorubicin in resistant cells.